US equities |
SPCX $171.09 ▲+0.00% NVDA $238.90 ▲+0.00% MU $1,063.96 ▲+0.00% SDEV $3.94 ▲+0.00% SNDK $1,704.16 ▲+0.00% SKHY $195.02 ▲+0.00% TSLA $378.73 ▲+0.00% INTC $116.19 ▲+0.00%
FinancialContent

Articles published by Apollomics, Inc.

News headline image
Apollomics Co-Founder and President, Sanjeev Redkar, Ph.D., to Speak at 23rd Annual R. Bryan Miller Symposium
From Apollomics, Inc.
Via GlobeNewswire
Tickers APLM APLMW
News headline image
Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq
From Apollomics, Inc.
Via GlobeNewswire
Tickers JMAC
News headline image
Apollomics Announces Completion of Business Combination and Listing on Nasdaq
From Apollomics, Inc.
Via ACN Newswire
Tickers JMAC JMACU
News headline image
Apollomics Inc. Receives FDA Orphan Drug Designation for Vebreltinib (APL-101) for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor Aberrations
From Apollomics, Inc.
Via GlobeNewswire
Tickers JMAC JMACU JMACW
News headline image
Apollomics Inc. Expands Leadership Team with Appointment of Jane Wang, PhD as Chief Scientific Officer
From Apollomics, Inc.
Via GlobeNewswire